These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28590545)

  • 1. The utility of a single simple question in the evaluation of patients with myasthenia gravis.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
    Muscle Nerve; 2018 Feb; 57(2):240-244. PubMed ID: 28590545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modified rankin scale to assess disability in myasthenia gravis: Comparing with other tools.
    Farrugia ME; Carmichael C; Cupka BJ; Warder J; Brennan KM; Burns TM
    Muscle Nerve; 2014 Oct; 50(4):501-7. PubMed ID: 24639179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the italian version of the 15-item Myasthenia Gravis Quality-of-Life questionnaire.
    Raggi A; Leonardi M; Ayadi R; Antozzi C; Maggi L; Baggi F; Mantegazza R
    Muscle Nerve; 2017 Oct; 56(4):716-720. PubMed ID: 28029697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological testing is correlated with myasthenia gravis severity.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Rt MN; Bril V
    Muscle Nerve; 2017 Sep; 56(3):445-448. PubMed ID: 28029691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the 15-item myasthenia gravis quality of life questionnaire (MG-QOL15) Persian version.
    Ostovan VR; Fatehi F; Davoudi F; Nafissi S
    Muscle Nerve; 2016 Jun; 54(1):65-70. PubMed ID: 26661455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers.
    Barnett C; Katzberg H; Nabavi M; Bril V
    J Clin Neuromuscul Dis; 2012 Jun; 13(4):201-5. PubMed ID: 22622164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).
    Pasqualin F; Barnett C; Guidoni SV; Albertini E; Ermani M; Bonifati DM
    Neurol Sci; 2022 Mar; 43(3):2059-2064. PubMed ID: 34505205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.
    Burns TM; Sadjadi R; Utsugisawa K; Gwathmey KG; Joshi A; Jones S; Bril V; Barnett C; Guptill JT; Sanders DB; Hobson-Webb L; Juel VC; Massey J; Gable KL; Silvestri NJ; Wolfe G; Cutter G; Nagane Y; Murai H; Masuda M; Farrugia ME; Carmichael C; Birnbaum S; Hogrel JY; Nafissi S; Fatehi F; Ou C; Liu W; Conaway M
    Muscle Nerve; 2016 Dec; 54(6):1015-1022. PubMed ID: 27220659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-acceptable symptom states in myasthenia gravis.
    Mendoza M; Tran C; Bril V; Katzberg HD; Barnett C
    Neurology; 2020 Sep; 95(12):e1617-e1628. PubMed ID: 32759200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite.
    Burns TM; Conaway MR; Cutter GR; Sanders DB;
    Muscle Nerve; 2008 Dec; 38(6):1553-62. PubMed ID: 19016543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferior oblique muscle paresis as a sign of myasthenia gravis.
    Almog Y; Ben-David M; Nemet AY
    J Clin Neurosci; 2016 Mar; 25():50-3. PubMed ID: 26531848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness.
    de Meel RHP; Barnett C; Bril V; Tannemaat MR; Verschuuren JJGM
    J Neuromuscul Dis; 2020; 7(3):297-300. PubMed ID: 32250313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability of the Polish version of myasthenia gravis - Quality of life questionnaire - 15 item.
    Rozmilowska I; Adamczyk-Sowa M; Pierzchala K; Czyzewski D
    Neurol Neurochir Pol; 2017; 51(4):311-318. PubMed ID: 28579082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the Myasthenia Gravis Impairment Index.
    Barnett C; Bril V; Kapral M; Kulkarni A; Davis AM
    Neurology; 2016 Aug; 87(9):879-86. PubMed ID: 27402891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Office-based respiratory assessment in patients with generalized myasthenia gravis.
    Alcantara M; Barnett-Tapia C; Bril V; Mannan S; Shabanpour J; Riaz S; Ng E; Ryan C; Katzberg H
    Neuromuscul Disord; 2024 Jul; 40():1-6. PubMed ID: 38776756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.
    Barnett C; Bril V; Kapral M; Kulkarni AV; Davis AM
    Neurology; 2017 Dec; 89(23):2357-2364. PubMed ID: 29101274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any relationship between quality of life and polysomnographically detected sleep parameters/disorders in stable myasthenia gravis?
    Tascilar NF; Saracli O; Kurcer MA; Ankarali H; Emre U
    Acta Neurol Belg; 2018 Mar; 118(1):29-37. PubMed ID: 28456888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Oculobulbar Facial Respiratory score is a tool to assess bulbar function in myasthenia gravis patients.
    Farrugia ME; Harle HD; Carmichael C; Burns TM
    Muscle Nerve; 2011 Mar; 43(3):329-34. PubMed ID: 21305562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia Gravis Presenting as Persistent Unilateral Ptosis with Facial Droop.
    Golden SK; Reiff CJ; Painter CJ; Repplinger MD
    J Emerg Med; 2015 Jul; 49(1):e23-5. PubMed ID: 25797936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.